Alain J Cohen C4 Therapeutics, Inc. (CCCC) insider trading activity

CCCC Quotes by TradingView

Alain J Cohen is Director of C4 Therapeutics, Inc.. Currently has a direct ownership of 928 shares of CCCC, which is worth approximately $3,517. The most recent transaction as insider was on Apr 04, 2022, when has been sold 388 shares (Common Stock) at a price of $26.46 per share, resulting in proceeds of $10,266. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 928
0% 3M change
0% 12M change
Total Value Held $3,517

ALAIN J COHEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 04 2022
BUY
Grant, award, or other acquisition
$10,266 $26.46 p/Share
388 Added 29.48%
928 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
$10,042 $31.58 p/Share
318 Added 37.06%
540 Common Stock
Oct 04 2021
BUY
Grant, award, or other acquisition
$9,988 $44.99 p/Share
222 Added 50.0%
222 Common Stock
Jul 02 2021
BUY
Grant, award, or other acquisition
$9,970 $39.72 p/Share
251 Added 32.68%
517 Common Stock
Jun 14 2021
BUY
Other acquisition or disposition
-
61,877 Added 49.89%
62,143 Common Stock
Apr 05 2021
BUY
Grant, award, or other acquisition
$9,978 $37.51 p/Share
266 Added 50.0%
266 Common Stock
AJC

Alain J Cohen

Director
Watertown, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CCCC